| Jonathan C Stone, MD | |
|
5339 O'donovan Drive, Baton Rouge, LA 70808 | |
| (225) 766-4999 | |
| (225) 767-4702 |
| Full Name | Jonathan C Stone |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 15 Years |
| Location | 5339 O'donovan Drive, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225272578 | NPI | - | NPPES |
| 1927848 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD206294 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Our Lady Of The Lake Regional Medical Center | Baton rouge, LA | Hospital |
| Baton Rouge General Medical Center | Baton rouge, LA | Hospital |
| Womans Hospital | Baton rouge, LA | Hospital |
| Our Lady Of The Angels Hospital | Bogalusa, LA | Hospital |
| Surgical Specialty Center Of Baton Rouge | Baton rouge, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pathology Group Of Louisiana, A Professional Medical Corporation | 6507856317 | 22 |
News Archive
PharmAthene, Inc. today announced that the Delaware Court of Chancery has denied SIGA Technologies' motion for reargument filed on October 4, 2011, upholding the Court's original September 22, 2011 decision awarding PharmAthene 50% of the net profits over ten years from all sales of SIGA's smallpox antiviral therapeutic, ST-246, and related products, after SIGA receives the first $40 million in net profits.
The Treatabolome project is a research initiative to develop a freely available, interoperable online platform dedicated to disseminating rare disease and gene-specific treatment information to healthcare professionals regardless of their level of specialized expertise.
In 20 years, approximately 72 million older adults will reside in the United States, almost double the current number, according to the U.S. Administration on Aging. Potential issues are compounded by the projected shortage of health care workers needed to provide elder care. As part of the solution, an interdisciplinary team of University of Missouri researchers is refining electronic health record (EHR) technology to more efficiently meet increasing health care demands.
Aging disrupts the balance between bone formation and bone destruction, resulting in osteoporosis, which is characterized by reduced bone mass and increased risk of fracture. Recent data have suggested that this imbalance is a result of a decrease in formation of bone forming osteoblast cells from mesenchymal cells upon aging.
Researchers have unlocked mysteries surrounding how a pregnant mother's cells and her fetus' cells communicate throughout pregnancy.
› Verified 1 days ago
| Entity Name | Woman's Specialty Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366483315 PECOS PAC ID: 8921903048 Enrollment ID: O20031203000149 |
News Archive
PharmAthene, Inc. today announced that the Delaware Court of Chancery has denied SIGA Technologies' motion for reargument filed on October 4, 2011, upholding the Court's original September 22, 2011 decision awarding PharmAthene 50% of the net profits over ten years from all sales of SIGA's smallpox antiviral therapeutic, ST-246, and related products, after SIGA receives the first $40 million in net profits.
The Treatabolome project is a research initiative to develop a freely available, interoperable online platform dedicated to disseminating rare disease and gene-specific treatment information to healthcare professionals regardless of their level of specialized expertise.
In 20 years, approximately 72 million older adults will reside in the United States, almost double the current number, according to the U.S. Administration on Aging. Potential issues are compounded by the projected shortage of health care workers needed to provide elder care. As part of the solution, an interdisciplinary team of University of Missouri researchers is refining electronic health record (EHR) technology to more efficiently meet increasing health care demands.
Aging disrupts the balance between bone formation and bone destruction, resulting in osteoporosis, which is characterized by reduced bone mass and increased risk of fracture. Recent data have suggested that this imbalance is a result of a decrease in formation of bone forming osteoblast cells from mesenchymal cells upon aging.
Researchers have unlocked mysteries surrounding how a pregnant mother's cells and her fetus' cells communicate throughout pregnancy.
› Verified 1 days ago
| Entity Name | Pathology Group Of Louisiana, A Professional Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093843450 PECOS PAC ID: 6507856317 Enrollment ID: O20040514000007 |
News Archive
PharmAthene, Inc. today announced that the Delaware Court of Chancery has denied SIGA Technologies' motion for reargument filed on October 4, 2011, upholding the Court's original September 22, 2011 decision awarding PharmAthene 50% of the net profits over ten years from all sales of SIGA's smallpox antiviral therapeutic, ST-246, and related products, after SIGA receives the first $40 million in net profits.
The Treatabolome project is a research initiative to develop a freely available, interoperable online platform dedicated to disseminating rare disease and gene-specific treatment information to healthcare professionals regardless of their level of specialized expertise.
In 20 years, approximately 72 million older adults will reside in the United States, almost double the current number, according to the U.S. Administration on Aging. Potential issues are compounded by the projected shortage of health care workers needed to provide elder care. As part of the solution, an interdisciplinary team of University of Missouri researchers is refining electronic health record (EHR) technology to more efficiently meet increasing health care demands.
Aging disrupts the balance between bone formation and bone destruction, resulting in osteoporosis, which is characterized by reduced bone mass and increased risk of fracture. Recent data have suggested that this imbalance is a result of a decrease in formation of bone forming osteoblast cells from mesenchymal cells upon aging.
Researchers have unlocked mysteries surrounding how a pregnant mother's cells and her fetus' cells communicate throughout pregnancy.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan C Stone, MD 5339 O'donovan Drive, Baton Rouge, LA 70808 Ph: (225) 766-4999 | Jonathan C Stone, MD 5339 O'donovan Drive, Baton Rouge, LA 70808 Ph: (225) 766-4999 |
News Archive
PharmAthene, Inc. today announced that the Delaware Court of Chancery has denied SIGA Technologies' motion for reargument filed on October 4, 2011, upholding the Court's original September 22, 2011 decision awarding PharmAthene 50% of the net profits over ten years from all sales of SIGA's smallpox antiviral therapeutic, ST-246, and related products, after SIGA receives the first $40 million in net profits.
The Treatabolome project is a research initiative to develop a freely available, interoperable online platform dedicated to disseminating rare disease and gene-specific treatment information to healthcare professionals regardless of their level of specialized expertise.
In 20 years, approximately 72 million older adults will reside in the United States, almost double the current number, according to the U.S. Administration on Aging. Potential issues are compounded by the projected shortage of health care workers needed to provide elder care. As part of the solution, an interdisciplinary team of University of Missouri researchers is refining electronic health record (EHR) technology to more efficiently meet increasing health care demands.
Aging disrupts the balance between bone formation and bone destruction, resulting in osteoporosis, which is characterized by reduced bone mass and increased risk of fracture. Recent data have suggested that this imbalance is a result of a decrease in formation of bone forming osteoblast cells from mesenchymal cells upon aging.
Researchers have unlocked mysteries surrounding how a pregnant mother's cells and her fetus' cells communicate throughout pregnancy.
› Verified 1 days ago
Dr. Brian W. Webb, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 5339 Odonavan, Baton Rouge, LA 70808 Phone: 225-766-4999 Fax: 225-767-4702 | |
Zarius Drummond, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5339 O'donovan Drive, Baton Rouge, LA 70808 Phone: 225-766-4999 Fax: 225-767-4702 | |
Dr. Leo A. Pei, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 17000 Medical Center Drive, Baton Rouge, LA 70816 Phone: 225-752-2470 | |
Jennifer Jastram-belcher, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5339 O'donovan Drive, Baton Rouge, LA 70808 Phone: 225-766-4999 Fax: 225-767-4702 | |
Dr. Peggy H. Polk, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 5339 Odonavan, Baton Rouge, LA 70808 Phone: 225-766-4999 Fax: 225-763-5870 | |
Amberly Lindau Nunez, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 5339 Odonovan Dr, Baton Rouge, LA 70808 Phone: 225-766-4999 Fax: 225-767-4702 |